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Background. A few patients, after receiving solid organ transplantation, return to performing various sports and com-
petitions; however, at present, data no study had evaluated the effects of endurance cycling races on their renal function.
Methods.Race times and short form (36) health survey questionnaires of 10 kidney transplant recipients (KTR) and 8 liver trans-
plant recipients (LTR) transplanted recipients involved in a road cycling race (130 km) were compared with 35 healthy control sub-
jects (HCS), also taking laboratory blood and urine tests the day before the race, at the end of the race, and 18 to 24 hours after
competing. Results. The 3 groups showed similar race times (KTR, 5 hours 59 minutes ± 0 hours 39 minutes; LTR, 6 hours
20 minutes ± 1 hour 11 minutes; HCS, 5 hours 40 minutes ± 1 hour 28 minutes), similar short form (36) health survey scores,
and similar trend of laboratory parameters which returned to baseline after 18 to 24 hours. After the race, there was an increase
in creatinine (0.24 mg/dL; effect size [ES] = 0.78; P < 0.001), urea (22 mg/dL; ES = 1.42; P < 0.001), and a decrease of estimated
glomerular filtration rate (−17 mL/min; ES = 0.85; P < 0.001). The increase of blood uric acid was more remarkable in HCS and
KTR (2.3 mg/dL; ES = 1.39; P < 0.001). The KTR showed an increase of microalbuminuria (167.4 mg/L; ES = 1.20; P < 0.001)
and proteinuria (175 mg/mL; ES = 0.97; P < 0.001) similar to LTR (microalbuminuria: 176.0 mg/L; ES = 1.26; P < 0.001; protein-
uria: 213 mg/mL; ES = 1.18; P < 0.001), with high individual variability. The HCS had a nonsignificant increase of microalbuminuria
(4.4 mg/L; ES = 0.03; P = 0.338) and proteinuria (59 mg/mL; ES = 0.33; P = 0.084). Conclusions. Selected and well-trained
KTR and LTR patients can participate to an endurance cycling race showing final race times and temporarymodifications of kidney
function similar to those of HCS group, despite some differences related to baseline clinical conditions and pharmacological ther-
apies. Patients involved in this study represent the upper limit of performance currently available for transplant recipients and can-
not be considered representative of the entire transplanted population.
(Transplantation Direct 2015;1: e36; doi: 10.1097/TXD.0000000000000546. Published online 19 October 2015)Patients with solid transplanted organs are characterizedby high risk of cardiovascular disease1,2 and metabolic
syndrome associated to chronic inflammation at subclinic
status and sarcopenia.3,4 These medical conditions are mainly
caused by the side effects of the immunosuppressive therapy,
on a sedentary lifestyle,5,6 and by the chronic disease that led
to transplantation.
Several studies have shown the positive effects of physical
exercise in preventing primary and secondary cardiovascularReceived 17 June 2015. Revision received 27 August 2015.
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from a regular and practical application of physical activity
and sport as an opportunity to improve the health conditions
of transplanted patients, and to counteract the side effects
of the immunosuppressive therapy with the exercise. It is a
fact that there is a lack of awareness related to this topic
and a widespread hesitation of the patients and their families.
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tients returning to sports activities at amateur or professional
level after a successful transplantation. The analysis of these
experiences10,11 allows to give original information concern-
ing the usefulness of physical activity and sport in trans-
planted patients, opening the question if a resumed or a newly
started sporting activity could be dangerous for the safety
of the graft.
The aim of this paper is to contribute to answering this
question, studying the kidney function in a group of trans-
planted patients involved in a long-distance road cycling race.
MATERIALS AND METHODS
Subjects
In recent years, a small group of transplanted patients out
of the about 12 000 participants has taken part in the Nove
Colli road cycling race. Among these, we selected male sub-
jects, aged between 18 and 80 years, kidney or liver trans-
planted at least 1 year before, who usually practice cycling
and voluntarily participate in the race. Recruitment was pos-
sible through the help of AssociazioneNazionale Emodializzati,
Dialisi e Trapianto Sport, an association involved in promoting
the participation of transplanted patients in sports events.
Eighteen transplanted patients divided in 10 kidney trans-
plant recipients (KTR) (mean ± SD age, 50 ± 6 years; weight,
73 ± 6 kg; height, 1.74 ± 0.04m; BMI, 24.2 ± 2.6 kg/m2; time
from transplant, 9.5 ± 6.5 years; length of dialysis treatment
before transplantation 22 ± 18 months, range 3-59), and 8
liver transplant recipients (LTR) (mean±SDage, 57±13years;
weight, 72 ± 3 kg; height, 1.76 ± 0.01 m; BMI, 23.1 ±
1.1 kg/m2; time from transplant, 9.0 ± 4.4 years)were recruited.
Pathologies leading to the transplant in the group of KTR
were: glomerulonephritis (n = 3), nephroangiosclerosis (n = 2),
polycystic kidney disease (n = 2), end-stage kidney disease
(n = 2); and in the LTR group: cirrhosis HCV-related (n = 4),
HBV-related (n = 2), primary sclerosing cholangitis (n = 1),
liver damage from medications (n = 1). Regarding the daily
immunosuppressive therapy, in KTR group, 6 patients were
assuming tacrolimus (trough level, 5.6 ± 1.6 μ/g per liter), 4
cyclosporine (trough level, 130 ± 35 ng/mL); in 5 patients,
calcineurin inhibitors were associated with steroid therapy
(methylprednisolone 4 ± 2 mg), in 6 patients with inhibitors
of DNA synthesis (mycophenolic acid, 720 ± 290 mg). In
4 LTR patients, the immunosuppressive therapy consisted
in Everolimus (trough level, 3.8 ± 0.8 ng/mL) and in the other
4 patients in tacrolimus (trough level, 4.6 ± 1.1 μ/g per liter)
associated in 2 case with steroids (methylprednisolone, 4 mg)
and in 2 cases to inhibitors of DNA synthesis (mycophenolic
acid, 720 mg).
All patients had good blood pressure control (BP <140/
80 mmHg). Seven patients were treated with angiotensin
converting enzyme (ACE) inhibitors (5 KTR, 2 LTR), 7 used
β-blockers (6 KTRs, 1 LTR). No patient was treated with
hypoglicemic therapy or erythropoietin.
Thirty-five matching men (age, 50 ± 10 years; weight,
74 ± 9 kg; height, 1.75 ± 0.06 m; BMI, 24.1 ± 2.3 kg/m2)
who usually practice cycling and voluntarily participate in
the short route of the same race were recruited as healthy
control subjects (HCS), with the help of the organization of
the race, through a newsletter and e-mail sent to all the partic-
ipants. They reported no significant clinical problem,with BPCopyright © 2015 The Authors. Transplantation Dvalues within the normal range (BP < 140/80 mm Hg). One
subject was taking regular treatment with ACE inhibitors
and another one occasionally took steroids.
The Race
“Nove Colli” is a long-distance cycling road race that
takes place in Romagna (Forlì-Cesena and Rimini, Italy),
with starting grid and finish line placed at sea level in
Cesenatico. It is one of the most prestigious events of this
kind, one of the oldest (held since 1971), and probably one
of the most known not only in Italy for this type of competi-
tions. The race is open only to leisure and amateur cyclists
whomust submit a validmedical certificate of fitness for road
cycling competitions. The maximum number of race entries
is 12 000. Participants were divided into 7 departure grids
at 3-minute intervals from each other. Before starting, partic-
ipants can choose between a short route (130 km) and a long
route (200 km). The transplanted patients chose the short
route, as 63% of the participants that were considered in
the present study as HCS. The characteristics of the route
were: length, 130 km; total uphill gradient, 1 871 m; uphill
riding, 50 km over 4 hills; downhill riding, 46 km; flat ter-
rain, 34 km; maximum riding time allowed, 7.5 hours.
Protocol
The study was divided into different control phases:
(i) a baseline overall medical assessment of all the subjects,
with collection of anamnestic data, information on drug
therapy, measurement of resting heart rate and BP, assess-
ment of the subjective perception of the health-related
quality of life with the short form (36) health survey
(SF-36) questionnaire, as well as with an ad hoc question-
naire investigating the level of training carried out
throughout the year and in preparation for the race.
(ii) Collection of venous blood and urine samples at time 1
(T1) (the day before the race), time 2 (T2) (immediately af-
ter crossing the finish line), and time 3 (T3) (18-24 hours
after competing).
(iii) In addition, at T2 the amount of fluid ingestion (mL) dur-
ing the race was recorded by direct question and marked
in a register.
(iv) Athletes observation at T2 (post) and 3 (18-24 hours) in-
cluded the assessment of possible adverse events during
or after the race. The investigators used a specific case re-
port form to record the results of the clinical assessment.
Laboratory Methods
The testing laboratory of S. OrsolaHospital (Bologna) car-
ried out the blood chemistry and urinalysis assessments.
We collected 30 mL of venous blood (whole blood) from
the antecubital vein and 30 mL of urine from all participants
in the study for each time. Blood sampling was done in a
sitting position and fasting at T1 and T3. Blood and urine
samples were stored at room temperature and subsequently
transported to the laboratory analysis with suitable transport.
The blood samples were centrifuged for 5 minutes in a
bench-top centrifuge 3 500 rpm (rcf: 2465 xg) at 20 to 22 °C
immediately after their arrival in the laboratory.
The following laboratory tests (ADVIA 2120; Hematology
System, Siemens, Erlangen, Germany) were carried out on the
samples: complete blood count with flow cytometry and
light-scattering, hemoglobin (g/dL) with optical colorimetricirect. Published by Wolters Kluwer Health, Inc.
© 2015 Wolters Kluwer Mosconi et al 3method, leukocytes (103/mm3) with peroxidase and baso-
phils methods (cytochemical reactions), and lymphocytes
(%) with cytochemical reactions.
Renal function parameters: creatinine (mg/dL) with Jaffè
method, estimated glomerular filtration rate (eGFR) withMod-
ification of Diet in Renal Diseases formula (isotope dilution
mass spectrometrymethod,mass spectrometry isotope dilution
calibrated), urea (mg/dL) with urease and glutamate dehydro-
genase, uric acid (mg/dL) with enzymatic colorimetric test.
Urinalysis: urine specific gravity (densimetry), urine sedi-
ment (optical microscope), microalbuminuria (mg/L) (nephe-
lometry), and proteinuria (mg/1000 mL) (turbidimetry).
The reports of the analysis were sent privately to each
participant.
Organizational Aspects
The study team included a physician and a nurse for collec-
tion of medical history and blood tests, and a researcher in-
volved in the distribution and collection of questionnaires.
The SF-36 questionnaire and an ad hoc questionnaire in-
vestigating the amount of training performed during the year,
and general information as well, have been administered be-
fore taking the first blood sample on the day before the race.
The study was conducted in the respect of well-
acknowledged ethical standards and national/international
legislation. This trial was carried out in compliance with In-
ternational Conference onHarmonisationGuidelines forGood
Clinical Practice, with the Declaration of Helsinki and with
national rules regarding clinical trial management.
The participants were informed about the nature of the re-
search, assurances of anonymity, and their right to withdraw
at any time. Written informed consent was obtained by the par-
ticipants before inclusion, according to the procedures approved
by the Ethical Committee of the Italian Institute of Health.
STATISTICAL ANALYSIS
Unless otherwise indicated, the data are presented as the
mean ± standard deviation. After verifying the assumptions
of normality and homoscedasticity, 1-way analysis of vari-
ance for independent samples were used to compare the
mean values for the SF-36 questionnaire, quantity of training
questionnaire, and the fluid ingestion during the competition
between KTR, LTR, and HCS. Significance was set at P less
than 0.05. When appropriate, post hoc Bonferroni tests have
been used for pairwise comparisons. Linear mixed models
were used to test the effect of group and sampling time on
blood and urinary parameters. Fixed effects were included
for group, time, and their interaction, and a random intercept
and effect of time were included for individual cyclists.
Models of best fit were selected using a stepwise selection
method. The HCS group and the pre-race time point were
set as reference values for group and time, respectively. When
significantly different from 0 (P < 0.05), raw coefficients were
reported for fixed effects (and their interaction) with 95%
confidence intervals, whereas standardized coefficients were
reported as the effect size (ES). Statistical analyses were car-
ried out using the software R, version 3.0.3.
RESULTS
The race started at 6.30 AM of May 18, 2014. Weather
conditions were good, with a temperature of 12.6°C at the
start and of 18.9°C at 12 noon.Copyright © 2015 The Authors. Transplantation DiAll the participants completed the route without adverse
events. There was no significant difference (P > 0.41) in the
average time race between the 3 groups (5 hours 59 minutes ±
0 hour 39 minutes in KTR, 6 hours 20 minutes ± 1 hour
11 minutes in LTR, 5 hours 40 minutes ± 1 hours 28 minutes
in HCS).
No significant differences were found in the quantity of
training expressed as amount of training workouts per week
(3.1 ± 0.6 KTR, 3.6 ± 1.8 LTR, 2.8 ± 1.1 HCS; P = 0.21) and
hours of training for each session (2.6 ± 0.8 KTR, 2.8 ± 0.7
LTR, 2.8 ± 0.8 HCS; P = 0.77).
With respect to hydration status, no significant differences
(P = 0.10) were found in the amount of fluid ingestion during
the race (KTR, 2000 ± 500 mL; LTR, 1833 ± 764 mL; HCS,
2533 ± 1067 mL).
Complete Blood Count
The value of hemoglobin before the race was significantly
lower in KTR versus HCS, with a difference of 1 mg/dL
(ES = 0.73; P = 0.009); the difference between LTR and
HCS was not significant. The 3 groups showed the same
trend of the hemoglobin values after performing physical ef-
fort. The level was unchanged at T2, whereas there was a sta-
tistically significant decrease at T3, the level being 0.9 mg/dL
(ES = 0.67; P < 0.001) lower versus baseline. However, the
data remained within the normal range, and the observed
change had no clinical significance. Leukocytes showed a high
variability. When compared with HCS, baseline values were
higher in KTR versus HCS (difference of 1.17  103/mm3;
ES, 0.29; P = 0.004) and lower in LTR (difference of
1.72  103/mm3; ES, 0.42; P < 0.001). The trend after the
race was similar for the 3 groups. We observed a significant
increase of leukocytes at T2 in HCS (difference of 8.36 
103/mm3; ES, 2.06; P < 0.001); the changes were less remark-
able in TR, and in particular in LTR (LTR−4.29 103/mm3 vs
HCS; ES, 1.05; P < 0.001; KTR −2.32 103/mm3 vs HCS; ES,
0.57;P = 0.0023). At T3, there is a general and uniform trend
to return to baseline values, even though the leukocyte count
was on average slightly higher (0.66  103/mm3; ES, 0.16;
P = 0.005).
As for the percentage of lymphocytes, there were no signif-
icant differences at T1 between HCS, KTR, and LTR. The
general trend at T2 and T3 was similar in all the groups. At
T2, there was a marked decrease both in HCS and in LTR
(−22.2%; ES, 2.00; P < 0.001); this change was less evident
in KTR (ES, 0.65; P < 0.001). At T3, there was a trend back
to the baseline values in all the groups. In general, the per-
centage of lymphocytes remained slightly lower in HCS and
LTR (difference of 3.5%; ES, 0.31; P < 0.001). Descriptive
data are shown in Table 1.
Renal Function
Both the HCS and the LTR showed renal function tests in
the normal range at T1. The KTR group had values of creat-
inine and urea slightly higher than normal, and significantly
higher versus HCS and LTR (P < 0.001 for both variables).
The changes at T2 were similar in the 3 groups, with a signif-
icant increase of creatinine (0.24 mg/dL; ES, 0.78; P < 0.001)
and urea (22mg/dL; ES, 1.42; P < 0.001) and a significant de-
crease of eGFR (−17 mL/min; ES, 0.85; P < 0.001).
The increase of blood uric acid was more remarkable in
HCS and KTR (2.3 mg/dL; ES, 1.39; P < 0.001). At T3, allrect. Published by Wolters Kluwer Health, Inc.
TABLE 1.
Complete blood count (Mean ± SD) at 3 different times of analysis: before the race (Time 1), after (Time 2), and the day after the
race (Time 3)
Hemoglobin, g/dL Leukocytes, 103/mm3 Lymphocytes, %
Kidney transplant recipients (KTR, N = 10) Time 1 (pre) 13.7 ± 1.2a,b 6.86 ± 1.44 30.1 ± 6.2
Time 2 (post) 13.4 ± 1.9 12.89 ± 4.08c 15.1 ± 8.1c
Time 3 (18-24 h) 12.9 ± 1.3b 7.78 ± 3.06 30.4 ± 8.8
Liver transplant recipients (LTR, N = 8) Time 1 (pre) 15.3 ± 1.6b 3.97 ± 0.66 33.3 ± 8.4
Time 2 (post) 15.2 ± 1.7 8.04 ± 1.06c 9.8 ± 3.6c
Time 3 (18-24 h) 14.5 ± 1.8b 4.53 ± 0.50 30.8 ± 5.5
HCS (N = 35) Time 1 (pre) 14.8 ± 0.7a,b 5.69 ± 1.03 30.8 ± 5.7
Time 2 (post) 14.8 ± 0.9 14.05 ± 2.75c 8.6 ± 2.9c
Time 3 (18-24 h) 13.9 ± 0.8b 6.35 ± 1.39 27.3 ± 5.7
Laboratory reference values 12.0-15.0 4.20-9.00 19.0-48.0
a P < 0.05 in time 1 hemoglobin between KTR vs HCS.
b P < 0.05 in time 1 and time 3 hemoglobin between each group.
c P < 0.05 in Time 2 leukocytes and in lymphocytes in each group.
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but the urea and uric acid values remained higher than the av-
erage. Descriptive data are shown in Table 2.
Urinalysis
The baseline values of urine specific gravity were lower in
KTR (−5; ES = 0.68) and in LTR (−2; ES = 0.28), vs HCS. At
T2, the values were practically stable in all the groups.
There was a significantly different trend in the following
period: at T3, we observed a significant increase in HCS (9;
ES, 1.30; P < 0.001); this increase was present also in LTR,
even though less remarkable and at the border of significance
(−4; ES, 0.57; P = 0.063). In KTR, the values did not show
changes versus baseline.
We did not observe cases of significant changes of urine
sediment after the race. At T2 and T3, there was a micro-
hematuria (20-40 red blood cells per field) in 10% of KTR,
12% of LTR, and 14% of HCS.
In KTR and LTR, the baseline values of microalbuminuria
and proteinuria were slightly higher than normal. The trend
of the 2 parameters was similar in the 3 groups at the different
observation times. In particular, at T2, we observed in KTR,
a significant increase of microalbuminuria (167.4 mg/L; ES,
1.20; P < 0.001) and proteinuria (175 mg/mL; ES, 0.97; P <TABLE 2.
Renal function (Mean ± SD) at 3 different times of analysis: befo
(Time 3)
Creatinine, mg/dL
KTR (N = 10) Time 1 (pre) 1.25 ± 0.40a
Time 2 (post) 1.52 ± 0.55
Time 3 (18-24 h) 1.41 ± 0.46
LTR (N = 8) Time 1 (pre) 0.89 ± 0.16a
Time 2 (post) 1.10 ± 0.21
Time 3 (18-24 h) 0.92 ± 0.09
HCS (N = 35) Time 1 (pre) 0.92 ± 0.14a
Time 2 (post) 1.15 ± 0.22
Time 3 (18-24 h) 0.99 ± 0.14
Laboratory reference values 0.50-1.20
a P < 0.001 in time 1 creatinine, eGFR and urea in each group.
b P < 0.001 in time 2 uric acid between KTR and HCS.
Copyright © 2015 The Authors. Transplantation D0.001). Similar increasewere observed inLTR (microalbuminuria:
176.0 mg/L; ES = 1.26; P < 0.001; proteinuria: 213 mg/mL;
ES = 1.18; P < 0.001), with a high individual variability.
Also, the HCS had an increase of both parameters
(microalbuminuria: 4.4 mg/L; ES = 0.03; P = 0.338; protein-
uria: 59 mg/mL; ES = 0.33; P = 0.084), without statistically
significant differences versus baseline. All groups showed a
trend to return to baseline at T3.
In KTR, microalbuminuria and proteinuria at T3 were
lower than at baseline. Descriptive data are shown in Table 3.
Health-Related Quality Of Life
Table 4 shows the descriptive statistics of SF-36 scales, in
transplanted recipients (KTR and LTR) compared to HCS.
No significant differences were found in any of the SF-36
questionnaire scales between the 3 groups.
DISCUSSION
The data of the present study show that it is possible for a
selected group of kidney and liver transplanted patients to
participate to a long-distance cycling race with chronometric
results superimposable to those of healthy amateur cyclists.
These transplanted recipients are characterized by the capac-
ity to express the same amount of training workouts perre the race (Time 1), after (Time 2), and the day after the race
eGFR, mL/min Urea, mg/dL Uric acid, mg/dL
61 ± 25a 51 ± 12a 6.5 ± 1.0
51 ± 25 70 ± 16 8.3 ± 1.7b
59 ± 31 69 ± 19 8.2 ± 2.0
83 ± 13a 38 ± 12a 4.7 ± 1.1
60 ± 5 58 ± 17 5.6 ± 1.5
85 ± 14 51 ± 6 5.2 ± 0.5
87 ± 13a 38 ± 8a 4.6 ± 0.8
69 ± 15 61 ± 11 6.9 ± 1.4b
84 ± 14 54 ± 8 6.0 ± 0.9
>60 15-50 3.4-7.0
irect. Published by Wolters Kluwer Health, Inc.
TABLE 3.
Urinalysis (Mean ± SD) at 3 different times of analysis: before the race (Time 1), after (Time 2), and the day after the race (Time 3)
Urine-Specific gravity Microalbuminuria, mg/L Proteinuria, mg/1 000 mL
KTR (N = 10) Time 1 (pre) 1 015 ± 5 68.4 ± 96.3a 182 ± 126a
Time 2 (post) 1 017 ± 5 266.7 ± 376.2b 416 ± 425b
Time 3 (18-24 h) 1 015 ± 6c 34.1 ± 59.4d 100 ± 68
LTR (N = 8) Time 1 (pre) 1 017 ± 3 47.2 ± 36.0e 163 ± 47e
Time 2 (post) 1 016 ± 6 254.1 ± 295.5f 435 ± 383f
Time 3 (18-24 h) 1 022 ± 4 54.7 ± 61.7g 205 ± 171g
HCS (N = 35) Time 1 (pre) 1 019 ± 6b 8.1 ± 15.6a,e 73 ± 43a, e
Time 2 (post) 1 021 ± 6 38.2 ± 47.2b,f 131 ± 83b,f
Time 3 (18-24 h) 1 027 ± 4a,b 12.3 ± 24.1d,g 103 ± 48g
Laboratory reference values 1 010-1 025 <25 <200
a In microalbuminuria and proteinuria, P < 0.01 Time 1 between KTR and HCS.
b In microalbuminuria and proteinuria, P < 0.01 Time 2 between KTR and HCS.
c P < 0.05 Time 3 urine specific gravity between KTR and HCS.
d In microalbuminuria and proteinuria, P < 0.01 Time 3 between KTR and HCS.
e In microalbuminuria and proteinuria, P < 0.01 Time 1 between LTR and HCS.
f In microalbuminuria and proteinuria, P < 0.01 Time 2 between LTR and HCS.
g In microalbuminuria and proteinuria, P < 0.01 Time 3 between LTR and HCS.
h P < 0.05 between Time 1 and Time 3 in HCS.
© 2015 Wolters Kluwer Mosconi et al 5week and hours of training for each session compared to
healthy amateur cyclists, as a prerequisite necessary to take
advantage of their performance capacities. Obviously, these
patients had no contraindications to participate in a road cy-
cling races; they were checked every 6 months by their trans-
plant center for many years after receiving transplantation,
and the immunosuppressive therapies were well tolerated.
These patients are also characterized by a subjective percep-
tion of personal physical, psychological, and emotional needs
comparable to the population of healthy subjects, allowing
them to achieve a level of quality of life similar to the general
population of active individuals.12,13 In these transplant re-
cipients, this 130-km cycling race induces physiological mod-
ifications of kidney function, urinalysis, and complete blood
count, similar to that observed in healthy amateur cyclists
with a return to baseline values in the recovery period after
the end of the competition. Furthermore, all the investigated
parameters had a similar trend both in transplanted and
healthy subjects, despite some differences related to the base-
line clinical conditions.
The KTR showed lower hemoglobin levels, on average,
at all times. We can argue that in these patients, the mild de-
crease of eGFR (61 ± 25 mL/min) may contribute to the de-
velopment of a state of relative anaemia. A slight decrease
of hemoglobin was recorded in all the groups (KTR, LTR,
and HCS) after the race, in particular at T3. Among the pos-
sible causes, we could recognize an increase of blood volume
induced by the endurance physical activity.14 Both groups ofTABLE 4.










KTR 10 100 ± 2 98 ± 8 86 ± 18 68
LTR 8 99 ± 2 94 ± 18 100 ± 0 83
HCS 35 96 ± 18 94 ± 19 90 ± 20 75
Copyright © 2015 The Authors. Transplantation Ditransplant recipients showed, like HCS, a significant increase
of leukocytes and a decrease of the percentage of lympho-
cytes immediately after the race. The lower increase of the
leukocyte number in transplant recipients versus HCS was
observed also in another study,15 and may be a consequence
of the immunosuppressive treatment. The significant changes
induced by physical stress on the immune system and the
inflammation status are a very interesting research field and
suggest the opportunity to carry out additional tests (like
cytokines).16,17
Considering the parameters of renal function, there were
similar changes in the 3 groups after about 6 hours of race cy-
cling, with significant increase of creatinine, urea and uric
acid, and decrease of eGFR (Table 2). In all 3 groups, the
functional parameters, in particular creatinine and eGFR,
showed a trend to baseline values after 18 to 24 hours; the
persistence of higher values of urea and uric acid may be
the result of a temporary status of hypercatabolism.18 The
higher values of creatinine, urea and uric acid, and the lower
values of eGFR in KTR observed at T1, T2, and T3 are com-
patible with the condition of “single kidney.” This may also
be the effect of the treatment with calcineurin inhibitors (va-
soconstrictor effect on afferent arterioles), which were the
basis of immunosuppressive therapy in our KTR.19 This
may also be the result of the treatment with ACE inhibitors,
used in 5 of 10 KTRs.
The absence of changes in specific gravity after the race








± 22 71 ± 12 86 ± 11 97 ± 11 77 ± 15
± 12 72 ± 9 87 ± 18 75 ± 35 81 ± 11
± 13 74 ± 12 91 ± 13 92 ± 20 76 ± 16
rect. Published by Wolters Kluwer Health, Inc.
6 Transplantation DIRECT ■ 2015 www.transplantationdirect.comcapacity of urine concentration. This is compatible with a
chronic tubular damage by chronic allograft nephropathy
andmay be partly induced by therapy with calcineurin inhib-
itors.19 The capacity to concentrate urine was only slightly
reduced in LTR. This finding probably depends on the
smaller tubular damage due to the different management of
the immunosuppressive therapy as suggested by the fact that
only 50% of our LTR used calcineurin inhibitors, also with a
lower dosage compared with KTR.
It is well known that the intensity of physical exercise may
cause reversible albuminuria and proteinuria20 which are
considered physiologic findings in the healthy sporting popu-
lation, even if the underlying physiopathologic mechanism
is not yet clearly defined. Different hypotheses include varia-
tions of glomerular hemodynamics and a reduced protein ab-
sorption at tubular level.21 This study shows that in KTR and
in LTR groups, the levels of microalbuminuria and protein-
uria were higher at all times versus HCS. In all the 3 groups
of subjects considered in the present study, the micro-
albuminuria and proteinuria resolved after resting. More-
over, the values of these parameters were similar in the
2 groups of transplant recipients. This is partly unexpected,
because LTRs have native kidneys that usually do not have
organic chronic kidney diseases before transplantation. In
our LTR, a long period after the transplant (9 years on aver-
age) seems to be compatible with glomerular and tubulo-
interstitial modifications, despite a good renal function.22 It
is also possible to hypothesize a role of immunosuppressive
therapy with mechanistic target of rapamycin inhibitors
(4 LTR treated of 8)23 even though the large variability of
data does not allow definitive conclusions and needs fur-
ther investigations.
The main limit of this study is the rather small number of
patients and the fact that these patients represent the upper
limit of performance currently available for transplant recip-
ients. In anyway, they cannot be considered representative of
the entire transplanted population. However, transplanted
patients involved in cycling races are very few, and we re-
cruited all those involved in the race for this study.Moreover,
they are far from being homogeneous in terms of age, time
from transplantation, pathology leading to transplantation,
and immunosuppressive therapy, which represent other limits.
Regarding the kidney function, because of logistic prob-
lems, it was not possible to determine the urinary excretion
of creatinine during the competition. However, the observed
variations of blood parameters were in accordance with the
literature after endurance physical effort.24,25
Another limit is the short duration of the follow-up after
the race (only 18-24 hours). The possible appearance of ad-
verse effects after several years of cycling (might manifest af-
ter 2 to 10 years) should be investigated with further studies.
In conclusion, data collected on transplant recipients who
practice sports activities can help us to understand their po-
tential performance capacities, and overall they raise the
question whether physical exercise, and eventually sport,
can be included among the therapies after receiving solid or-
gan transplantation.
This study showed that selected and well-trained kidney
and liver transplant recipients can participate to an endur-
ance cycling race showing performances comparable to those
of nontransplanted amateur cyclists. After the race, these
transplant recipients showed transient modifications of theCopyright © 2015 The Authors. Transplantation Dkidney function similar to those of healthy amateur cyclists
despite some differences related to their baseline clinical con-
ditions and pharmacological therapies.
At present, the results of this study indicate that the
transplanted patients can be involved in proper training and
endurance competitions, showing no adverse effects after
performing sports activities, but they need a careful clinical
monitoring and training. In this way, in the long term, it is
possible that the positive effects of physical activity will over-
come the potential risks of temporary modifications of some
parameters of organ function after exercise. Further studies
with longer survey periods, and possibly with greater number
of patients, are necessary to better understand the impact of
endurance training and sports activities on kidney function
of transplanted patients.
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